X P Li1, S Zeng, M Wang, X P Wu, E Y Liao. 1. Department of Clinical Laboratory, The Second Xiangya Hospital of Central South University, No. 139, Middle Renmin Road, Changsha, 410011, China.
Abstract
PURPOSE: The present study is firstly designed to identify the relationship between serum omentin-1 concentration, body fat mass and bone mineral density in healthy Chinese male adults in Changsha city. METHODS: A total of 219 (20-80 years old) healthy subjects were enrolled in this cross-sectional study. Serum omentin-1, adiponectin, leptin, resistin and bone turn over biochemical markers were measured with enzyme-linked immunosorbent assay. Bone mineral density (BMD) and fat body composition were determined using dual-energy-X-ray absorptiometry. RESULTS: Serum omentin-1 levels in the overweight subjects were significantly lower than those of the subjects with normal weight (p < 0.05). Omentin-1 was negatively correlated with weight (r = -0.418), body mass index (BMI, r = -0.419), waist circumference (r = -0.402), waist-to-hip ratio (WHR, r = -0.355), fat body mass (FBM, r = -0.430), fat % (r = -0.408), trunk fat (-0.431). However, after controlling for age, BMI and FBM, no significant correlation was noticed between omentin-1 and BMD at different skeletal sites. Pearson's correlation coefficients and partial correlation coefficients after adjustment showed no significant correlations between omentin-1 and bone turn over biochemical markers, including bone-specific alkaline phosphatase and bone cross-linked N-terminal telopeptides of type I collagen. Multiple line stepwise regression analysis revealed that FBM, WHR, adiponectin were important variables affecting omentin-1. Moreover, lean tissue mass was the most important factor affecting BMD and explained 10.5-14.7 % of the variance. Omentin-1, leptin and resistin were not the predictors of BMD. CONCLUSIONS: Serum omentin-1 was negatively correlated with FBM and BMI in healthy Chinese male adults, It was not significantly correlated with bone turnover biochemical markers. Omentin-1 may exert ambiguous effects on BMD, which maybe caused by the complex interactions among adipokines, hormonal activity, and body composition and bone metabolism.
PURPOSE: The present study is firstly designed to identify the relationship between serum omentin-1 concentration, body fat mass and bone mineral density in healthy Chinese male adults in Changsha city. METHODS: A total of 219 (20-80 years old) healthy subjects were enrolled in this cross-sectional study. Serum omentin-1, adiponectin, leptin, resistin and bone turn over biochemical markers were measured with enzyme-linked immunosorbent assay. Bone mineral density (BMD) and fat body composition were determined using dual-energy-X-ray absorptiometry. RESULTS: Serum omentin-1 levels in the overweight subjects were significantly lower than those of the subjects with normal weight (p < 0.05). Omentin-1 was negatively correlated with weight (r = -0.418), body mass index (BMI, r = -0.419), waist circumference (r = -0.402), waist-to-hip ratio (WHR, r = -0.355), fat body mass (FBM, r = -0.430), fat % (r = -0.408), trunk fat (-0.431). However, after controlling for age, BMI and FBM, no significant correlation was noticed between omentin-1 and BMD at different skeletal sites. Pearson's correlation coefficients and partial correlation coefficients after adjustment showed no significant correlations between omentin-1 and bone turn over biochemical markers, including bone-specific alkaline phosphatase and bone cross-linked N-terminal telopeptides of type I collagen. Multiple line stepwise regression analysis revealed that FBM, WHR, adiponectin were important variables affecting omentin-1. Moreover, lean tissue mass was the most important factor affecting BMD and explained 10.5-14.7 % of the variance. Omentin-1, leptin and resistin were not the predictors of BMD. CONCLUSIONS: Serum omentin-1 was negatively correlated with FBM and BMI in healthy Chinese male adults, It was not significantly correlated with bone turnover biochemical markers. Omentin-1 may exert ambiguous effects on BMD, which maybe caused by the complex interactions among adipokines, hormonal activity, and body composition and bone metabolism.
Authors: Rong-Ze Yang; Mi-Jeong Lee; Hong Hu; Jessica Pray; Hai-Bin Wu; Barbara C Hansen; Alan R Shuldiner; Susan K Fried; John C McLenithan; Da-Wei Gong Journal: Am J Physiol Endocrinol Metab Date: 2006-03-10 Impact factor: 4.310
Authors: Celia L Gregson; Margaret A Paggiosi; Nicola Crabtree; Sue A Steel; Eugene McCloskey; Emma L Duncan; Bo Fan; John A Shepherd; William D Fraser; George Davey Smith; Jon H Tobias Journal: J Clin Endocrinol Metab Date: 2013-01-21 Impact factor: 5.958
Authors: Sara A Armaiz-Flores; Nichole R Kelly; Ovidiu A Galescu; Andrew P Demidowich; Anne M Altschul; Sheila M Brady; Van S Hubbard; Courtney K Pickworth; Marian Tanofsky-Kraff; Lauren B Shomaker; James C Reynolds; Jack A Yanovski Journal: Horm Res Paediatr Date: 2017-03-30 Impact factor: 2.852
Authors: Christoph H Saely; Andreas Leiherer; Axel Muendlein; Alexander Vonbank; Philipp Rein; Kathrin Geiger; Cornelia Malin; Heinz Drexel Journal: Data Brief Date: 2015-12-11
Authors: J Menzel; R Di Giuseppe; R Biemann; K Aleksandrova; O Kuxhaus; C Wittenbecher; A Fritsche; M B Schulze; B Isermann; H Boeing; C Weikert Journal: J Endocrinol Invest Date: 2016-09-10 Impact factor: 4.256